Alten enjoyed high organic growth in Q2 2022, despite challenging comps. Revenue growth was 18.9% yoy at cc/cs. The performance was strong given that Q1 2021 revenues were up +19.7%. This is the fifth consecutive quarter of ~20% organic growth.
Alten Finishes 2021 with an Indian-like Growth Rate
lten finished 2021 with an India-growth rate. For the third consecutive quarter, Alten has an organic (cc/cs) revenue growth close to 20%, reaching 23.2% in Q4. The company benefitted from favorable comps (-17.4% in Q4 2020) and HR decisions.
Alten, the Largest and Fastest-Growing in Q3!
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org
Alten Now Positioned on Mid-Sized Acquisitions
Alten Using Mid-Sized Acquisitions to Counterbalance the Pandemic Impact Alten had told investors it would increase
Will Alten Be A Significant Clinical Trials CRO?
ER&D services largest pure-play, Alten, has ambitions as a clinical trials contract research organization (CRO). During Q2 2021, the company completed the acquisition of Cmed. Cmed, a clinical trial CRO based in the UK. It is a small firm with EUR 20m in revenues and 180 consultants. It has specialized in oncology, immuno-oncology, cell therapy, and rare disease.
Alten: A Big Rebound in Q2
Alten impressed investors with its Q2 rebound: revenues had a big rebound (+19.7% yoy at cc/cs) to EUR 714m. We had anticipated this solid rebound: the comps were very favorable (Q2 2020 was down 18.4% yoy organically).
Alten: Toward A Growth Acceleration in Q2!
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org.
Alten Makes its Largest Acquisition Ever, in Digital
Alten is to make its largest acquisition, with Milan-headquartered SDG Group. SDG has revenues of EUR 76m and a headcount of 950. Its operating margin is ~10%. We estimate the price paid by Alten to ~EUR 60m.
Europe Has Entered its Second Lockdown. A Look at Financial Implications
Europe has now entered its second lockdown. The lockdowns have different restrictions levels and different lengths. The UK and France are running for the full month of November. Officials in the two countries have, however, warned the lockdown might last longer, until Christmas at least.
Alten Accelerates its M&A Activity
Alten will accelerate its M&A activity in 2020. This is one of the tactical changes that the company announced during its H1 2020 results presentation. The company is also shifting its commercial effort to financial services, energy, and life science, and slightly accelerating its offshore deployment.
Alten Does Better than Expected in Q2. H2 Outlook Is Uncertain
Alten announced better than expected revenues in Q2 with a CC/CS decline of 18.4% (we expected -23%), after a growth of 4.0% in Q1. During H1, the decline was 7.3% (guidance: -9%).
Unofficial: Renault Selects its Four ER&D Preferred Vendors
According to unofficial sources, Renault has now finalized its list of preferred ER&D service vendors, reducing it from nine vendors to four. The four winners are Akka, Bertrandt, Expleo, and Segula. They will now grab 80% of Renault’s ER&D spending and double their market shares.
Earnings Preview: Revenues of Alten to Plunge in Q2
ER&D’s largest pure-play globally, Alten, will be announcing its Q2 2020 revenue by the end of July. The company had a very decent Q1, with a 4% CC/CS revenue growth. However, it warned that revenues would be down by ~22% in Q2.
Renault Considering R&D Outsourcing to Save EUR 200m Annually
Renault is considering R&D outsourcing to save EUR 100-200m annually. The company currently works with approximately 15 ER&D vendors and wants to reduce its number of preferred partners to five.
PSA To Deploy Systematically Work at Home Policy
During the crisis, PSA more than doubled the number of employees WaH from 18,000 concurrent connections to its IT to 38,000.
Outlook for the Aerospace Industry: A True Paradigm Shift
The Aerospace Industry’s Outlook Has Changed in Less Than Two Months We now have visibility on
Alten Slows Down in Q4. Points to Market Adjustment
Alten’s revenues in Q4 slowed down to a growth of +7.3% yoy (at CC/CS ), following double-digit CC/CS growth during Q1-Q3 2019. The company suffered from a demanding comparison basis (+13.7% in Q4 2018), and one lesser working day in several countries (a 0.15% impact on the group’s revenues).
Alten Points to Slowing Market in 2020 Despite Good Performance in Q3 2019
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org.
Alten accelerates its effort on Industry 4.0
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org
Alten: simply impressive!
The performance of Alten remained impressive in H1 2019: revenues were up 16.8% yoy at CC, and up 12.5% at CC/CS, reaching EUR 1,292m during the period.
Alten best-in-class in Q2, as always
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org
Alten adds EUR 100m in revenues this quarter
Alten impressed, again, with its growth performance. In Q1 2019, revenue growth (at CC/CS yoy) reached +12.5%, to EUR 643m. This quarter, Alten added almost EUR 100m in revenues, two-thirds of it through organic growth and one third through acquisitions. The Forex impact was negligible.
How will 2019 look like for the ER&D services industry?
We are now entering the season for Q1 earnings, and as always we will look into changes in major trends. The state of the automotive industry will be an area we will be closely monitoring.
Alten’s strategic plan: more of the same!
Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org.
ER&D services rankings: the winner is…
We have created an interim ranking of the top ten ER&D service vendors. Several large ER&D